Literature DB >> 8869938

Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. II: Deleterious consequences.

T D Miale1, S Sirithorn, S Ahmed.   

Abstract

There has been a dramatic improvement in the treatment of both allogeneic and autologous stem cell transplants, especially in children and young adults. However, attempts to apply more intensive conditioning treatments to the more refractory pediatric malignancies have also increased the risks of deleterious consequences. This review examines the risks, and reports important variations in the toxic effects of using different conditioning techniques.

Entities:  

Mesh：

Year:  1996        PMID： 8869938     DOI： 10.1007/bf02988840

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  119 in total

1.  Interstitial pneumonitis and venocclusive disease of the liver after bone marrow transplantation.

Authors:  P Piedbois; G Ganem; C Cordonnier; C Levy; V Benk; J M Pavlovitch; M F Saint-Marc Giradin; M Kuentz; G Marinello; J J Mazeron
Journal:  Radiother Oncol       Date:  1990       Impact factor: 6.280

2.  Early deaths in children undergoing marrow ablative therapy and bone marrow transplantation.

Authors:  E Psiachou; I M Hann; G Morgan; J M Chessells
Journal:  Bone Marrow Transplant       Date:  1994-12       Impact factor: 5.483

3.  Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission.

Authors:  T H Kim; P B McGlave; N Ramsay; W Woods; B Bostrom; G Vercellotti; D Hurd; W Krivit; M Nesbit; R Haake
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-10       Impact factor: 7.038

4.  Outcome of pregnancy in survivors of Wilms' tumor.

Authors:  F P Li; K Gimbrere; R D Gelber; S E Sallan; F Flamant; D M Green; R M Heyn; A T Meadows
Journal:  JAMA       Date:  1987-01-09       Impact factor: 56.272

5.  Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.

Authors:  E Gluckman; I Jolivet; M L Scrobohaci; A Devergie; R Traineau; H Bourdeau-Esperou; P Lehn; P Faure; L Drouet
Journal:  Br J Haematol       Date:  1990-03       Impact factor: 6.998

6.  Growth and development following marrow transplantation for leukemia.

Authors:  J E Sanders; S Pritchard; P Mahoney; D Amos; C D Buckner; R P Witherspoon; H J Deeg; K C Doney; K M Sullivan; F R Appelbaum
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

7.  Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females.

Authors:  S Spinelli; S Chiodi; A Bacigalupo; A Brasca; M V Menada; A R Petti; G Ravera; F Gualandi; M T VanLint; M Sessarego
Journal:  Bone Marrow Transplant       Date:  1994-09       Impact factor: 5.483

8.  Short-term endocrine consequences of total body irradiation and bone marrow transplantation in children treated for leukemia.

Authors:  M Ryalls; H A Spoudeas; P C Hindmarsh; D R Matthews; D M Tait; S T Meller; C G Brook
Journal:  J Endocrinol       Date:  1993-02       Impact factor: 4.286

9.  Breast cancer after treatment of Hodgkin's disease.

Authors:  S L Hancock; M A Tucker; R T Hoppe
Journal:  J Natl Cancer Inst       Date:  1993-01-06       Impact factor: 13.506

10.  Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study.

Authors:  S Phipps; M Brenner; H Heslop; R Krance; D Jayawardene; R Mulhern
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483
View more
  2 in total

1.  Pharmacological immunosuppression reduces but does not eliminate the need for total-body irradiation in nonmyeloablative conditioning regimens for hematopoietic cell transplantation.

Authors:  Marco Mielcarek; Beverly Torok-Storb; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-08       Impact factor: 5.742

2.  Growth hormone protects human lymphocytes from irradiation-induced cell death.

Authors:  Laurence Lempereur; Daria Brambilla; Giovanna Maria Scoto; Maria D'Alcamo; Vincent Goffin; Lucia Crosta; Tullio Palmucci; Liborio Rampello; Renato Bernardini; Giuseppina Cantarella
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.